|
Originally published In Press as doi:10.1074/jbc.M311532200 on January 15, 2004
J. Biol. Chem., Vol. 279, Issue 13, 12093-12101, March 26, 2004
Intestinal Tumor Progression Is Associated with Altered Function of KLF5*
Nicholas W. Bateman ,
Dongfeng Tan ,
Richard G. Pestell¶,
Jennifer D. Black , and
Adrian R. Black ||
From the
Departments of Pharmacology and Therapeutics and Pathology, Roswell Park Cancer Institute, Buffalo, New York 14263 and the ¶Department of Oncology, Lombardi Cancer Center, Georgetown Medical Center, Washington, D. C. 20057
Krüppel-like transcription factors have been linked to cell growth regulation and tumorigenesis in a number of systems. In the intestinal epithelium, expression of KLF5 (IKLF/BTEB2) is limited to proliferating crypt cells, indicating a growth-promoting role. Consistent with this role, we demonstrate that expression of KLF5 in non-transformed intestinal epithelial cells (ileal IEC-18 and Immorto-Min Colon Epithelial (IMCE) cells) enhances colony formation, cyclin D1 transcription, and cell growth. However, in contrast to these effects in non-transformed cells, KLF5 reduced colony number, failed to enhance cyclin D1 transcription, and was negatively correlated with cell growth in colon cancer cell lines. The relationship between tumor progression and KLF5 was further investigated using Ras-mediated transformation of IEC-18 and IMCE cells as syngeneic models. Ras-transformation recapitulated differences in the effects of KLF5 on cell growth and cyclin D1 transcription, providing a direct link between intestinal tumor progression and altered function of KLF5. Ras-transformation also markedly down-regulated KLF5; further analysis indicated that reduced expression of KLF5 mRNA and destabilization of KLF5 protein occur in intestinal tumors. Reduced levels of KLF5 mRNA were also detected in APCmin mouse and human familial adenomatous polyposis adenomas compared with normal crypt epithelium, indicating that down-regulation of KLF5 is an early event in intestinal tumorigenesis in vivo. Collectively, these data indicate that intestinal tumor progression is associated with a change in the growth-related functions of KLF5 and that intestinal tumors down-regulate KLF5 expression by multiple mechanisms.
Received for publication, October 21, 2003
, and in revised form, January 13, 2004.
* This work was supported by the Roswell Park Alliance Foundation, the Mae Stone Goode Foundation, National Institutes of Health Grants DK54909 and DK60632, and Roswell Park Cancer Center Core Grant CA16056. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
This article is dedicated to the late Dr. Alexander Bloch in recognition of his support and encouragement.
|| To whom correspondence should be addressed: Dept. of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263. Tel.: 716-845-3090; Fax: 716-845-8857; E-mail: adrian.black{at}roswellpark.org.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Guo, K.-W. Zhao, X.-Y. Dong, X. Sun, and J.-T. Dong
Acetylation of KLF5 Alters the Assembly of p15 Transcription Factors in Transforming Growth Factor-{beta}-mediated Induction in Epithelial Cells
J. Biol. Chem.,
July 3, 2009;
284(27):
18184 - 18193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Suzuki, D. Sawaki, K. Aizawa, Y. Munemasa, T. Matsumura, J. Ishida, and R. Nagai
Kruppel-like Factor 5 Shows Proliferation-specific Roles in Vascular Remodeling, Direct Stimulation of Cell Growth, and Inhibition of Apoptosis
J. Biol. Chem.,
April 3, 2009;
284(14):
9549 - 9557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Guo, X.-Y. Dong, X. Zhang, K.-W. Zhao, X. Sun, Q. Li, and J.-T. Dong
Pro-proliferative Factor KLF5 Becomes Anti-proliferative in Epithelial Homeostasis upon Signaling-mediated Modification
J. Biol. Chem.,
March 6, 2009;
284(10):
6071 - 6078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wan, F. Luo, S. E. Wert, L. Zhang, Y. Xu, M. Ikegami, Y. Maeda, S. M. Bell, and J. A. Whitsett
Kruppel-like factor 5 is required for perinatal lung morphogenesis and function
Development,
August 1, 2008;
135(15):
2563 - 2572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yang, M.-P. Tetreault, Y. A. Yermolina, B. G. Goldstein, and J. P. Katz
Kruppel-like Factor 5 Controls Keratinocyte Migration via the Integrin-linked Kinase
J. Biol. Chem.,
July 4, 2008;
283(27):
18812 - 18820.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. G. Goldstein, H.-H. Chao, Y. Yang, Y. A. Yermolina, J. W. Tobias, and J. P. Katz
Overexpression of Kruppel-like factor 5 in esophageal epithelia in vivo leads to increased proliferation in basal but not suprabasal cells
Am J Physiol Gastrointest Liver Physiol,
June 1, 2007;
292(6):
G1784 - G1792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. X. Du, C. C. Yun, A. Bialkowska, and V. W. Yang
Protein Inhibitor of Activated STAT1 Interacts with and Up-regulates Activities of the Pro-proliferative Transcription Factor Kruppel-like Factor 5
J. Biol. Chem.,
February 16, 2007;
282(7):
4782 - 4793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yang, B. G. Goldstein, H. Nakagawa, and J. P. Katz
Kruppel-like factor 5 activates MEK/ERK signaling via EGFR in primary squamous epithelial cells
FASEB J,
February 1, 2007;
21(2):
543 - 550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Chen, A. K. Seth, and A. E. Aplin
Genetic and Expression Aberrations of E3 Ubiquitin Ligases in Human Breast Cancer
Mol. Cancer Res.,
October 1, 2006;
4(10):
695 - 707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Sur, B. Rozell, V. Jaks, A. Bergstrom, and R. Toftgard
Epidermal and craniofacial defects in mice overexpressing Klf5 in the basal layer of the epidermis
J. Cell Sci.,
September 1, 2006;
119(17):
3593 - 3601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Hizli, A. R. Black, M. A. Pysz, and J. D. Black
Protein Kinase C {alpha} Signaling Inhibits Cyclin D1 Translation in Intestinal Epithelial Cells
J. Biol. Chem.,
May 26, 2006;
281(21):
14596 - 14603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. I. Fenton and N. G. Hord
Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research
Carcinogenesis,
May 1, 2006;
27(5):
893 - 902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Tong, K. Czerwenka, G. Heinze, M. Ryffel, E. Schuster, A. Witt, S. Leodolter, and R. Zeillinger
Expression of KLF5 is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients with Breast Cancer
Clin. Cancer Res.,
April 15, 2006;
12(8):
2442 - 2448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Chen, X. Sun, P. Guo, X.-Y. Dong, P. Sethi, X. Cheng, J. Zhou, J. Ling, J. W. Simons, J. B. Lingrel, et al.
Human Kruppel-like Factor 5 Is a Target of the E3 Ubiquitin Ligase WWP1 for Proteolysis in Epithelial Cells
J. Biol. Chem.,
December 16, 2005;
280(50):
41553 - 41561.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|